Effects of Motor Control Exercises With and Without Pressure Biofeedback in Recurrent Low Back Pain (MCE) (yes)

November 12, 2026 updated by: Salman Bashir, University of Management and Technology Lahore

Effects of Motor Control With and Without Pressure Biofeedback-Guided Training on Pain, Transversus Abdominis Activation and Disability in Patients With Recurrent Low Back Pain

This study aims to compare the effects of Motor Control Exercises (MCE) with and without Pressure Biofeedback-Guided Training in patients with recurrent low back pain. It will evaluate the effectiveness of both interventions in reducing pain, improving Transversus abdominis (TrA) muscle activation, and decreasing disability. The study will determine whether adding pressure biofeedback to motor control exercises provides better clinical outcomes than motor control exercises alone.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • University of Management & Technology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients aged 18-45 years with recurrent low back pain
  • Both male and female participants
  • Mild to moderate low back pain with a NPRS Scale score of 3-6 out of 10
  • History of at least two episodes of low back pain within the past 12 months
  • Absence of radiating pain below the gluteal fold
  • Ability to perform the Abdominal Drawing-In Maneuver (ADIM)

Exclusion Criteria:

  • Specific low back pain attributable to identifiable pathological conditions
  • Active lumbar radiculopathy accompanied by neurological deficits
  • Referred or radiating pain extending below the gluteal fold
  • Diagnosed spinal conditions, including disc herniation, spinal stenosis,
  • Medical conditions potentially associated with low back pain e.g tumors
  • History of surgery for low back pain within the past 12 months
  • Pregnancy
  • Current participation in another physiotherapy or rehabilitation program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Motor Control Training with Pressure Bio-feedback

Participants will receive 45-minute sessions comprising a 5-minute warm-up, 35-minute Motor Control Exercises (MCE), and 5-minute cool-down, guided by Pressure Biofeedback (PBU).

Weeks 1-2: ADIM, diaphragmatic breathing, multifidus activation, and heel slides (2-3 sets × 10 repetitions).

Weeks 3-4: Straight leg raises, double-leg lowering, bridging, and quadruped arm/leg extensions (3 sets × 8-10 repetitions).

Weeks 5-6: Standing ADIM, partial squats, planks, and sit-to-stand exercises (3 sets × 10 repetitions; planks 20-45 seconds).

Active Comparator: Motor Control Training

Participants will receive the same 45-minute Motor Control Exercise (MCE) program as in experimental group, including warm-up, phased exercises (Weeks 1-6), and cool-down, with identical sets, repetitions, hold times, rest intervals, and progression criteria, but without Pressure Biofeedback (PBU). Standardized verbal instructions and tactile cues (TrA palpation) will guide muscle activation. The same physiotherapist will supervise both groups, with exercise completion and adverse events recorded in session logs.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Numeric Pain Rating Scale
Time Frame: Baseline, 3 weeks and 6 weeks post treatment

Pain intensity will be assessed using the Numeric Pain Rating Scale, an 11-point scale ranging from 0 to 10, where 0 represents no pain and 10 represents the worst imaginable pain. Scores of 1-3 indicate mild pain, 4-6 indicate moderate pain, and 7-10 indicate severe pain. Higher scores indicate greater pain intensity and a worse outcome, while lower scores indicate less pain and a better outcome.

Baseline, 3 weeks and 6 weeks post treatment
Revised Oswestry Disability Questionnaire
Time Frame: Baseline, 3 weeks and 6 weeks post treatment

The Revised Oswestry Disability Questionnaire is a valid and reliable 10-item questionnaire. Each item is scored 0-5, with total disability expressed as a percentage: 0-20% (minimal), 21-40% (moderate), 41-60% (severe), 61-80% (crippled/severe functional limitation), and 81-100% (very severe disability). Higher scores indicate greater disability.

Baseline, 3 weeks and 6 weeks post treatment
Rehabilitative Ultrasound Imaging
Time Frame: Baseline, 3 weeks and 6 weeks post treatment

Rehabilitative Ultrasound Imaging (RUSI) is a non-invasive, reliable technique used to assess deep trunk muscle morphology, thickness, and activation. Transversus Abdominis (TrA) activation will be evaluated by measuring muscle thickness at rest and during contraction. Changes in muscle thickness will serve as an indirect indicator of muscle activation and lumbopelvic stability.

Baseline, 3 weeks and 6 weeks post treatment
Pressure Biofeedback
Time Frame: Baseline, 3 weeks and 6 weeks post treatment

The Pressure Biofeedback Unit (PBU) is a non-invasive device consisting of an inflatable pressure cell and gauge that provides visual feedback to improve lumbopelvic control during motor control exercises. It helps enhance abdominal muscle recruitment, reduce lumbopelvic instability, and improve movement control in patients with chronic low back pain.

Baseline, 3 weeks and 6 weeks post treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 20, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Study Registration Dates

First Submitted

October 17, 2026

First Submitted That Met QC Criteria

October 17, 2026

First Posted (Actual)

October 23, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 12, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • RE-167-2026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Time Frame

6 months after the publication of the manuscript.

IPD Sharing Access Criteria

The data can be requested from the corresponding author

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.